Companies/JP/4569

KYORIN PHARMACEUTICAL CO., LTD. · 杏林製薬株式会社

Ownership & governance

Executives 5Directors 6Avg age 66Avg tenure 8.2y
Yutaka Ogihara
Chief Executive Officer
Age 59Since 2023-03-31

Executives5

Yutaka Ogihara
Chief Executive Officer
Age 59Since 2023-03-31
Yasushi Kurose
Director of Finance/CFO
Age 56Since 2023-03-31
Junichi Ishiyama
Chief Tech/Sci/R&D Officer
——
Noriaki Tamura
Compliance Officer
——
Michiro Onota
Corporate Officer/Principal
Age 65Since 2015-03-31

Board of directors6

Yutaka Ogihara
Director/Board Member
Age 59Since 2011-05-31
Noriyuki Shikanai
Director/Board Member
Age 78Since 2013-05-31
Michiro Onota
Director/Board Member
Age 65Since 2015-03-31
Ken Shigematsu
Director/Board Member
Age 77Since 2017-05-31
Hiromi Watanabe
Director/Board Member
Age 79Since 2019-05-31
Yasushi Kurose
Director/Board Member
Age 56Since 2024-05-31

Shareholders5

NameStakeShares
Ogihara Family
19.84 %
11,895,000
Kopernik Global Investors LLC
8.746 %
5,242,800
Kyorin Group Employee Ownership Plan
3.542 %
2,123,000
KYORIN PHARMACEUTICAL CO., LTD.
3.003 %
1,800,000
Luchesu KK
2.936 %
1,760,000

Catalog · 2026-07-09

Registry officers11

NameRoleSinceShares
大野田 道郎取締役2014-04-01-
山口 隆央監査役2013-06-01-
松本 臣春常勤監査役2005-04-01-
森田 憲右監査役2010-11-01-
池村 幸雄監査役2009-04-01-
渡邉 弘美取締役2010-04-01-
荻原 豊代表取締役社長2011-06-01-
重松 健取締役1991-03-01-

Registry · as of 2026-03-31

Institutional (13F)

Loading Form 13F holders…

Fund membership

Loading fund baskets…

Street consensus

Consensus noneMean target 1,100Range 1,100–1,100Analysts 1
  • Strong sell 1

Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.

Peers